---
figid: PMC7232267__JDI-11-516-g005
figlink: pmc/articles/PMC7232267/figure/jdi13219-fig-0005/
number: F5
caption: 'Micro ribonucleic acid (miRNA) cross‐talk between miR 29 and miR let‐7 in
  the anti‐endothelial mesenchymal transition action of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline
  (AcSDKP). AcSDKP increases the levels of fibroblast growth factor receptor 1 (FGFR1)
  and, subsequently, miR let‐7s are induced. MiR let‐7 suppressed transforming growth
  factor β receptor (TGFβR1) and downstream Smad3 signaling, the major miR 29 inhibitory
  pathway. Therefore, the cells treated with AcSDKP also show induction of miR 29.
  miR 29 suppressed profibrotic and inflammatory cytokines and proteins, such as interferon‐γ,
  dipeptidyl peptidase‐4(DPP‐4) and so on. Interferon‐γ is known to suppress FGFR1.
  Interestingly, DPP‐4 inhibitor‐mediated suppression of DPP‐4 subsequently induced
  miR 29, and such DPP‐4 inhibitor‐activated miR 29 induced FGFR1‐dependent miR let‐7,
  as vice versa.[Correction added on 1 April 2020, after first online publication:
  The figure has been amended to match the original.]'
pmcid: PMC7232267
papertitle: 'N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic
  peptide for kidney fibrosis in diabetes: An update and translational aspects.'
reftext: Keizo Kanasaki. J Diabetes Investig. 2020 May;11(3):516-526.
pmc_ranked_result_index: '76129'
pathway_score: 0.9665031
filename: JDI-11-516-g005.jpg
figtitle: Micro ribonucleic acid (miRNA) cross‐talk between miR 29 and miR let‐7 in
  the anti‐endothelial mesenchymal transition action of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline
  (AcSDKP)
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7232267__JDI-11-516-g005.html
  '@type': Dataset
  description: 'Micro ribonucleic acid (miRNA) cross‐talk between miR 29 and miR let‐7
    in the anti‐endothelial mesenchymal transition action of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline
    (AcSDKP). AcSDKP increases the levels of fibroblast growth factor receptor 1 (FGFR1)
    and, subsequently, miR let‐7s are induced. MiR let‐7 suppressed transforming growth
    factor β receptor (TGFβR1) and downstream Smad3 signaling, the major miR 29 inhibitory
    pathway. Therefore, the cells treated with AcSDKP also show induction of miR 29.
    miR 29 suppressed profibrotic and inflammatory cytokines and proteins, such as
    interferon‐γ, dipeptidyl peptidase‐4(DPP‐4) and so on. Interferon‐γ is known to
    suppress FGFR1. Interestingly, DPP‐4 inhibitor‐mediated suppression of DPP‐4 subsequently
    induced miR 29, and such DPP‐4 inhibitor‐activated miR 29 induced FGFR1‐dependent
    miR let‐7, as vice versa.[Correction added on 1 April 2020, after first online
    publication: The figure has been amended to match the original.]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DPP4
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA7
  - IFNA8
  - IFNA17
  - IFNB1
  - IFNA6
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNW1
  - IFNK
  - FGFR1
  - SMAD3
  - TGFBR1
genes:
- word: DPP-4
  symbol: DPP4
  source: hgnc_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNW1
  entrez: '3467'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: DPP4
  symbol: DPP4
  source: hgnc_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: TGFBRI
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
chemicals: []
diseases: []
figid_alias: PMC7232267__F5
redirect_from: /figures/PMC7232267__F5
figtype: Figure
---
